• Text Size
  • Contrast
  • 2005/07/20
  • 3 min
  • 0

XENTION DISCOVERY LTD., an emerging pharmaceutical company specializing in ion channel drug discovery, announced today the closing of an £11 million ($20 million) Series B financing. New investors in the Company are ABN AMRO Capital of Amsterdam and Crédit Agricole Private Equity (CAPE) of Paris. Existing investors MVM, Quester, BTG International, Isis Equity Partners, Albany Ventures and Enterprise VCT plc all participated in the round alongside the new investors. ABN AMRO Capital led the financing. [...]

  • Taille du texte
  • Contraste

Erreur : "500 Internal Server Error".

Retour à l'accueil